available for iOS, Android & web
February 19, 2013
New draft guidance from NICE recommends that the NHS should use one test, Oncotype DX, to guide decisions about the use of chemotherapy in people with early breast cancer, but not three others.
Limited Marketer of the Year tickets available!
Read more here
PharmaTimes 2015 Copyright | RSS Feed Subscriptions